NR4A1 and breast carcinoma: These findings corroborate those reported previously by a Tanzanian study involving 60 patients immunostained for hormonal receptors at MNH and found that estrogen receptor expression among female breast cancer patients was 33% implying that majority of patients here are estrogen receptors negative [34].